Regulus Therapeutics Advances to Cohort 3 of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
SEC Filing | Larimar Therapeutics, Inc.
A Flow-chart of the single-ascending-dose (SAD) and... | Download Scientific Diagram
Adaptive and Innovative Study Designs to Accelerate Drug Development from First-In-Human to First-In-Patient
On Biostatistics and Clinical Trials: November 2017
Adaptive and Innovative Study Designs to Accelerate Drug Development from First-In-Human to First-In-Patient
Types of Study in Early Clinical Development - EUPATI Toolbox
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study | Nature Metabolism
Types of Study in Early Clinical Development - EUPATI Toolbox
Study design. Subjects in SAD cohort 4, part 2, were dosed in the fed... | Download Scientific Diagram
Quantitative Decision Making (QDM) in Phase I/II studies - ppt download
Frontiers | Molecular Signatures of Response to Mecasermin in Children With Rett Syndrome
Safety, tolerability of ES16001, a novel varicella zoster virus reactivation inhibitor, in healthy adults | European Journal of Medical Research | Full Text
Accelerating development with combined SAD/MAD approach
SEC Filing | Larimar Therapeutics, Inc.
Clinical development: present and future | Basicmedical Key
Study design with overlapping SAD-MAD cohorts, where treatment periods... | Download Scientific Diagram
On Biostatistics and Clinical Trials: SAD and MAD: Single Ascending Dose and Multiple Ascending Dose first-in-human studies
